Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1283 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

ADVENTRX inks agreement to acquire SynthRx

Poloxamer 188 is a nonionic block copolymer surfactant that minimizes the cascade of adhesive, inflammatory and coagulation responses that cause adhesion of cells, impaired blood flow and tissue

QPS acquires Taiwan-based toxicology unit of DCB

The Taiwan-based CTPS, which is an ISO/IEC 17025 certified, GLP compliant and AAALAC accredited facility specializing in general nonclinical toxicity and safety testing, genetic toxicology, reproductive toxicology, immunotoxicity